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Cytolytic  T  lymphocytes  (CTL) 1 are  thought  to  be  important  effector  cells  in 
immunity  to  virus  infection  and  in  allograft  rejection.  The  antigenic  specificity  of 
cytotoxicity mediated  by CTL has  now been documented  using cloned CTL popu- 
lations  (1-3).  This  specificity  is  mediated  through  antigen-specific  receptors  on the 
cell  surface.  The  receptor  specificities  of  alloreactive  CTL  and  their  precursors 
represent  phenotypic markers  which can be used  to distinguish  clonally distributed 
subpopulations  of  T  lymphocytes  that  otherwise  have  very  similar  cell  surface 
characteristics (4, 5). Under the appropriate culture conditions, this antigen specificity 
has been shown to be a  stable phenotypic property of cloned T  lymphocytes (5). 
Antisera  reactive with  specific populations  of cytolytic T  lymphocytes have been 
reported.  These  antisera  were  obtained  by  immunizing  mice  with  heterogeneous 
populations of cells derived from alloreactive mixed lymphocyte cultures  (MLC)  (6), 
or  activated  spleen  cells  reactive  with  trinitrophenyl  (TNP)-modified  (7)  or  virus- 
modified (8) target cells. Given the extremely diverse repertoire of CTL (2, 4), it seems 
unlikely that these antisera were reactive with individual idiotypes expressed by CTL. 
Recent studies in this laboratory have shown that cloned cytolytic T  lymphocytes are 
particularly  suited  as  a  source  of homogeneous  cells  for  use  in  functional  assays 
designed  to  identify  monoclonal  antibodies  reactive  with  cell  surface  structures 
associated with immunological functions (9). This approach has been used successfully 
to derive xenogeneic monoclonal antibodies  reactive with  the Lyt-2,3 (10)  and LFA- 
1 (9,  1 1) cell surface molecules.  In the present  study, this approach has been applied 
in the screening of hybridoma antibodies  potentially directed against  antigen recog- 
nition  structures  on  the  cloned  alloreactive  CTL  line,  L3  (12).  Here  we report  the 
production ofa monoclonal antibody, designated 384.5, that inhibits the lytic activity 
of  the  L3  CTL  clone.  This  antibody  is  distinguished  from  previously  reported 
antibodies  that  inhibit  cytolytic activity in  that  the  inhibition  is specific for the  L3 
cytolytic clone. The clone-specific nature  of the reactivity of this  antibody has been 
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confirmed by immunofluorescent labeling and analysis by immunofluorescence flow 
cytometry. 
Materials and Methods 
Experimental Animals.  Adult female mice of strains C57BL/6, CBA/J, DBA/2, and C57BL/ 
6  X  DBA/2  Fa  (BDFI)  were  obtained from The Jackson  Laboratory, Bar  Harbor,  ME,  or 
Laboratory Supply Co., Indianapolis, IN. Adult mice from strains B10.D2 and B10.A(5R)/Sgn 
were obtained as the progeny of breeding pairs obtained from The Jackson Laboratory and 
maintained at the University of Chicago. 
Cloned T  Lymphocytes.  CTL clones L3 and BI8 are ofC57BL/6 anti-DBA/2 origin (12). L3 
specifically  lyses target cells that express  surface antigens controlled by genes  located in the 
right half of the H-2 d haplotype of the major histocompatibility complex (MHC)  (5). B18 is 
specific for target cells expressing antigens controlled by the left half of the MHC, probably H- 
2K d (5). The CTL clones T18 and T38 were derived from primary C57BL/10 (B10) anti-TNP- 
B10  MLC  (13). Clone T18  specifically ggses TNP-modified target  cells  expressing H-2D ~ 
antigen. Clone T38 specifically lyses TNP-modified cells that bear H-2D  b'd's antigens. The CTL 
clones L3, B18, T18, and T38 express Lyt-2)2 antigen on their surface. 
The maintenance of the CTL clones L3 and B 18 has been described previously (3). Briefly, 
L3  and B18 cells were  maintained by weekly  restimulation with irradiated alloantigen and 
secondary MLC supernatant in Dulbecco's modified Eagle's medium (DME)  (H-21;  Gibco 
Laboratories, Grand Island Biological  Co., Grand Island, NY) containing 2% fetal calf serum 
(FCS)  (KC Biological,  Inc., Lenexa, KS),  100 U/ml penicillin, 100 #g/ml streptomycin, and 
additional (14) amino acids. Each well (Linbro 24-well plate, 76-033-05; Linbro Chemical Co., 
Hamden, CT) contained 2 ×  104 L3 or B18 cells, 6.5 ×  l0  s irradiated (1,400 rad)  (model 143 
cesium irradiator: JLS  Shepherd  & Associates,  Glendale, CA)  DBA/2 spleen cells, and 33% 
supernatant from  secondary  MLC  in'a final  volume of  1.6  ml.  Culture plates  were  then 
incubated in a 37°C 5% COz humidified incubator. 
Antibodies.  Monoclonal antibodies 2.43 (anti-Lyt-2.2), 3.155  (anti-Lyt-2), 15E  (anti-Thy- 
1.2), and 83A (anti-Thy-l.2) have been described (10, 15). Fluorescein isothiocyanate-coupled 
rabbit anti-mouse immunoglobulin (Ig) produced by one of the authors (M.  Loken)  has been 
described previously (16). 
Immunization Procedure.  BDFI mice were immunized five times, with each injection consisting 
of ~2 X  i0  T  cloned L3 CTL cells. The first injection was given intraperitonealIy in complete 
Freund's adjuvant  followed  at  3-wk  intervals by  intraperitoneat  injections in  incomplete 
Freund's adjuvant. Inhibitory effects on cytolysis of P-815 (H-2 't) target cells by L3 cloned CTL 
could be detected in the serum of animals after the fourth injection. 3 d before fusion, a final 
intraveneous injection of L3 cells was given. 
Fusion.  Spleen cells from immune BDF~ mice were fused with SP2/0-Agl4 (SP2/0) hybrid 
cells using the polyethylene glycol fusion procedure described by McKearn et al.  (17). 
Assays for Inhibition  of Cytolysis.  Microinhibition assays  for  the  screening and analysis of 
hybridoma supernatants were performed using the method of Dialynas et al.  (11). Briefly, the 
effector cells were incubated with antibody for 30 min at 4°C, followed by the addition of'~lCr  - 
labeled target cells and incubation  at 37°C for periods ranging from 30 to 90 min to induce the 
lyric injury. EDTA was then added to prevent further lysis, and cells were  incubated for an 
additional period of 2  3 h  to permit maximum release  of 51Cr. The effector/target cell ratio 
and  incubation times were  predetermined for  each  cloned CTL  to  provide the  maximum 
sensitivity for detection of inhibition of cytolysis. 
Inhibition  of cytolysis of several cloned CTL and of primary MLC cells was determined over 
a range of effector/target cell ratios using a short-term SlCr-release assay described previously 
(10). This procedure was  modified to  test  for  inhibition of cytolysis  under lectin-facilitated 
conditions by increasing the period of incubation before the addition of EDTA to provide for 
optimal specific 5~Cr release  from the targets. 
Fluorescence Staining and Flow @tofluorometric Analysis.  Indirect immunofluorescence  was used 
in all instances. Cloned CTL, normal tissue cells,,or 5 d  MLC cells were  centrifuged over a 
Ficoll-Hypaque gradient (18), washed thoroughly in medium and distributed for fluorescence 
staining. A two-stage technique was used with staining at room temperature in the presence of LANCKI ET AL.  923 
0.2% sodium azide. The first-step antibody was incubated under saturating conditions with 106 
cells for 15 min in 25 #1 total volume. Cells were washed by the addition of 75 #1 Dulbecco's 
phosphate-buffered saline (DPBS)  containing 5%  agammaglobulinemic horse  serum  (AGH) 
over a cushion of 25 #1 AGH, and centrifuged at 600 g for 15 rain. The second step reagent was 
fluorescein-coupled rabbit anti-mouse Ig that was added under saturating conditions in a final 
volume of 25 #1, and the cells were incubated and washed as described above. The stained cells 
were resuspended to a volume of 500 #1 in DPBS/5% AGH in the presence of propidium iodide 
(1.5 #g/ml) (19). 
Cells were analyzed using a fluorescence-activated cell sorter (FACS IV, B-D FACS Systems, 
Becton, Dickinson & Co., Sunnyvale, CA) equipped with a four decade logarithmic amplifier 
(Nozaki  Associates,  Inc., Palo Alto, CA). In all experiments, 104 viable ceils, as determined by 
exclusion of propidium iodide, were analyzed (19). 
Results obtained with experimental and control cell populations are presented as fluorescence 
histograms, with  the number of cells on the y  axis  and the  log of fluorescence intensity in 
arbitrary units on the x axis. 
Trypsin Treatment of L3  Cells.  Cloned  L3  cells  were  harvested  6-7  d  after  the  previous 
transfer, washed once in medium, and centrifuged over a 4-ml Ficoll-Hypaque gradient (18). 
Cells recovered from the interface were washed three times in medium and once in serum-free 
DME. Cells were resuspended in Hanks' balanced salt solution (without Ca  ++ or Mg  ++) at a 
concentration of 2  X  107  cells/ml.  An  equal  volume of trypsin  (Miles  Laboratories  Inc., 
Research Products Div., Elkhart, IN) at various concentrations  was added to the cell suspension, 
and the mixture was incubated at 37°C for 30 rain. Ice-cold DME (10 ml) with 20% FCS was 
added to stop the reaction. The cells were  washed three times in cold medium and counted. 
Overnight incubation of trypsin-treated cells was performed by culturing approximately 5 × 
106 L3 cells in 1 ml of medium in a plastic culture plate (76-033-05; Linbro Chemical Co.) The 
incubation was continued for  18 h at 37°C in a humidified 5% COz atmosphere. 
Mixed Lymphocyte Cultures.  Primary 5-d MLC cells were prepared as described previously 
(14). C57BL/6 responding cells  (25 ×  106) and irradiated (1,400 rad) stimulating cells  (25 × 
10  e')  from various strains were combined in a  final volume of 20 ml in plastic culture flasks 
(3024; Falcon Labware, Oxnard, CA). Cultures were allowed to incubate in a humidified 37°C 
incubator with a 5% COz atmosphere for 5 d. 
Secondary MLC cells were  generated from  12  14 d primary MLC by restimulating 3.5 × 
106 primary MLC cells with 25 X 106 irradiated stimulating spleen cells from the appropriate 
strain. Responding cells were harvested for cytofluorometric analysis at 96 h following restim- 
ulation. Alternatively, 48 h after restimulation MLC cells were cloned as described (3) by limit 
dilution culture. 
Results 
Fusion Results.  Sera from two mice which had been immunized with the L3 CTL 
clone cells (as described in Materials and Methods) were found to inhibit the lysis of 
the P-815 target cells by L3 but not by B 18 cells. Spleen cells from each of these mice 
were fused in separate fusions with myeloma cells, and the resulting hybrid cells were 
screened for clone-specific inhibition of cytolysis. The efficiency for the  first  fusion 
(microwells  with  growing  cells  per  total  microwells)  was  ~85%  (816/960).  The 
efficiency for the  second fusion was  ~82%  (1,180/1,440).  Two microwells from  the 
first  fusion and one microwell from  the  second  fusion produced supernatants that 
inhibited the cytolysis of P-815 target cells by L3 but not B18 cells. One established 
hybridoma (designated FP384) was obtained from a  microwell derived from the first 
fusion.  This  hybridoma was  recloned,  and  the  supernatants of that  recloned  line 
(designated 384.5)  were  used  in the  studies described below.  Monoclonal antibody 
384.5 is IgG3 (data not shown). 
The Clone-specific Nature of the Inhibition of Cytolysis by Monoclonal Antibody 384.5.  To 
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modified-self-reactivity were tested in antigen-mediated cytolytic assays in the pres- 
ence or absence of antibody 384.5.  Fig.  1 shows the characteristic inhibition profiles 
of 384,5  monoclonal antibody on the antigen-mediated lysis of P815 target cells by 
the CTL clones L3 and B18, in the microinhibition assay (9).  The cytolytic activity 
of CTL clone L3 (specific for H-2L a, unpublished data) was inhibited in the presence 
of 384.5 antibody over a  range of antibody concentrations, but the cytolytic activity 
of another CTL clone B 18 (specific for H-2K d) was unaffected over the same range of 
antibody concentrations. In contrast, a potent anti-Lyt-2 monoclonal antibody, 3.155, 
blocked  both  L3  and  B18  antigen-mediated  lysis  in  a  manner  consistent  with 
previously reported  inhibition studies  (9).  The  effects  of an  irrelevant monoclonal 
antibody (anti-Thy-l.2), 83A, are also shown for comparison in Fig.  1. The selective 
inhibition of L3 lytic activity by antibody 384.5 was tested over a  range of effector to 
target  cell  ratios by using several cloned cytolytic T  cell  lines, including B18,  T18 
(which  has  cytolytic specificity for TNP-modified self [H-2b]-antigen), and T38  (a 
CTL line which reacts against TNP-modified self [H-2b]- or TNP-modified alloanti- 
gen  [H-2Da])  (12).  The  results  shown  in  Table  I  indicate  that  the  monoclonal 
antibody  384.5  inhibited cytolytic activity  of the  CTL  clone  L3  over  a  range  of 
effector/target cell ratios. Antibody 384.5 failed to block TNP-specific H-2D a region- 
restricted lysis of TNP-modified P815 target cells by the CTL clone T38 or the lysis 
of TNP-modified EL-4 target ceils by the CTL clone T18 (Table I). In contrast, the 
nonpolymorphic anti-Lyt-2 antibody, 3.155,  strongly  inhibited L3,  T38,  and  T18 
cytolytic activities against their appropriate targets. We have now tested >90 short- 
term cytolytic clones derived from alloreactive MLC that were not inhibited by the 
antibody 384.5  (data not shown), 
Cytolytic activity of 5-d primary MLC cells is inhibited by treatment in the absence 
of complement with anti-Lyt-2 sera (20, 21), monoclonal antibodies (10), or with anti- 
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Fie-.  1.  Effects  of monoclonal antibody 384.5 on lysis  of P-815 target cells by CTL clones 1,3 and 
BI8. A fixed number of L3 (5 ×  10  a) or BI8 (1  ×  104  ) cells were preincubated for 30 min at 4°C 
with various dilutions of 3.155 (anti-Lyt-2), 83A (anti-Thy-l.2), or 384.5 supernatant  fluids and 
tested for cytotoxicity against 2,5 X 10  a 5~Cr-labeled P-815 target cells. After the addition of the 
target cells, incubation at '37°C was continued for 90 min (B18) or 60 rain (1,3) before the addition 
of EDTA to inhibit further lytic activity. Incubations were continued at 37°C for a total of 180 rain 
(B18) or 120 rain (L3) before harvesting. Results are expressed as the percent lysis relative to that 
in the absence of antibody (9). 
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TABLE  I 
Effects of Monoclonal Antibody 384.5 on Lysis by CTL Clones L3,  T18, and T38 
925 
Target cell  Effector cell  E/T ratio 
Monoclonal antibody added 
3.155  15E (Anti-  Medium  (Anti-  384.5 
Lyt-2)  Thy- 1.2) 
Percent specific lysis* 
P-815-TNP  L3  20  62  6  5  54 
7  56  3  4  44 
3  37  3  3  43 
T38  20  77  5  86  71 
7  66  1  79  64 
3  47  6  66  53 
C57BL/10-TNP  T18  20  76  2  74  71 
7  76  1  71  72 
3  62  0  68  66 
* Cloned CTL effector cells were preincubated with undiluted hybridoma culture supernatants  3.155 (anti- 
Lyt-2), 15E (anti-Thy  1.2), 384.5, or 20% AGH medium controls for 30 rain. The appropriate target cells 
(5 ×  103) were added and the mixture was incubated for 90 min before the addition of EDTA to inhibit 
further lytie activity. Incubations were continued  for an additional 90 min. The results are expressed as 
the percent specific lysis  at the indicated effector/target  cell ratio. 
170/100  (LFA-1)  monoclonal  antibodies  (9,  22).  To  determine  whether  antibody 
384.5  inhibited cytolysis by primary MLC  cells, 5-d unidirectional C57BL/6  MLC 
cells responding to DBA/2, B 10.D2, B 10.A(5R), or CBA stimulating cells were tested 
in a short-term 51Cr-release cytotoxicity assay in the presence of monoclonal antibodies 
384.5,  2.43  (anti-Lyt-2.2), 83A  (anti-Thy  1.2), or media controls. The data shown  in 
Table II indicate that antibody 384.5 did not strongly inhibit the cytolytic activity of 
MLC  cells  under  conditions  suitable  for  inhibiting  cytolysis of L3  cells  by  other 
monoclonal antibodies. The effects of antibody 384.5 on the cytolytic activity of MLC 
cells stimulated twice in vitro are also shown in Table II. The results indicate that the 
cytolytic  activity  of  MLC  cells  reactive  against  the  H-2 't  haplotype  or  against 
determinants  controlled  by  the  right  half of the  H-2 d  haplotype  [C57BL/6  anti- 
B 10.A(5R)] were not strongly inhibited by antibody 384.5. However, cytolytic activity 
was  significantly  reduced  when  MLC  cells  were  assayed  in  the  presence  of anti- 
Lyt-2.2 antibody 2.43. 
Antigen-specific cytolytic T  lymphocytes can  be  induced  in  the  presence  of the 
lectins, concanavalin A  (Con A) or phytohemagglutinin (PHA), to lyse inappropriate 
target  cells  (23)  by  a  mechanism  similar  to  antigen-mediated  cytolysis  (24).  CTL 
clones L3 and B18 were tested in lectin-facilitated ~aCr-release assays for their ability 
to lyse either syngeneic target cells, EL-4, or irrelevant allogeneic target cells, AKR-A, 
in the presence of antibody 384.5,  an anti-Lyt-2.2 antibody (2.43),  or medium.  The 
data  shown  in  Table  III  indicate  that  antibody  384.5  strongly  inhibited  Con  A- 
facilitated  cytolysis of both  EL-4  and  AKR-A  target  cells by  the  CTL  clone  L3. 
Interestingly,  antibody  384.5  did  not  strongly  inhibit  PHA-facilitated cytolysis of 
AKR-A  target  cells by the  L3  effector cells. We  have  also  tested  the  specificity of 
inhibition of lectin-facilitated lysis by antibody 384.5.  The  data presented in Table 
III show  that  antibody 384.5  did not  inhibit Con  A-facilitated cytolysis of EL-4 or 926  T  CELL  CLONE-SF'ECIFIC  MONOCLONAL  ANTIBODY 
TABLE  II 
Effects of Antibody 384.5 on the Cytolytic Aetzvity of Bulk MLC Cells* 
Target cell 
Percent specific lysis 
Effector cell  E/T  20%  83A  2.43 
ratio  AGH 
(Me-  (anti-  (anti- 
dium)  Thy-l.2)  Lyt-2.2) 
384.5 
P-815 
Primary MLC 
P-815 
AKR  -A 
Secondary MLC 
P-815 
L3  t0  73  69  1  14 
3  64  57  0  11 
B6 ~-DBA/2  30  68  69  27  68 
10  49  43  15  49 
3  28  26  11  24 
B6 a-BI0.D2  30  7l  74  25  65 
10  61  61  14  57 
3  45  35  10  36 
B6 a-B10.A(5R)  30  65  68  20  54 
10  52  58  17  44 
3  36  38  5  30 
B6 a-CBA  30  22  28  0  39 
10  20  17  0  30 
3  12  14  0  14 
B6 ~-DBA/2  30  20  25  2  23 
10  16  18  3  14 
3  12  7  0  8 
B6 a-B10.D2  30  24  26  2  27 
10  17  20  1  20 
3  i0  8  1  9 
B6 a-B 10.A(5R)  30  23  37  3  29 
10  25  20  4  25 
3  19  15  3  13 
* Effector cells obtained from the indicated MI,C were prcincubated with 20V, AGIt control or (undiluted) 
supernatants  from  hybridnmas  83A  (anti-Thy-l.2),  2.43 (anti-Lyt-2.2),  or  384.5 fi~r 30  min.  The 
appropriate target cells were added to the culture and the lyric reaction  was allowed  to proceed for 45 
rain. Lysis was stopped after 45 rain by the addition of EDTA and the incubation was continued for an 
additional 2 h. 
AKR-A  target  cells  by  BI8  effector  cells.  Furthermore,  the  lectin  PHA  did  not 
efficiently induce the B18 cells to lyse AKR-A  target cells. 
Specificity  of Binding of Monoclonal  Antibody 384.5.  We have investigated the expres- 
sion of the cell surface determinant  detected by monoclonal antibody 384.5 on cloned 
T  lymphocytes, 5-d  alloreactive  MLC  cells,  and  normal  murine  tissues  by  indirect 
immunofluorescence using flow cytofluorometric analysis. Fig.  2 A, shows the typical 
immunofluorescence profile observed with  antibody  384.5  on  L3  cloned CTL  cells. 
The  relative fluorescence intensity observed with antibody 384.5  was two and a  half 
times greater than when L3 was reacted with an  inappropriate third-party antibody 
(data  not  shown)  or  with  the  fluorescein-labeled second  antibody  alone.  When  the 
CTL  clone B 18  was tested under identical conditions the fluorescence histogram for LANCKI ET  AL.  927 
TABLE  III 
Effects of Monoclonal Antibody 384.5 on Lectin-facilitated Cytolysis by Cloned CTL L3 and B18 
Target cell  Lectin  Effector cell  E/T ratio 
Monoclonal antibody added 
Medium  2.43 (anti-  384.5 
Lyt-2.2) 
Percent specific lysis* 
EL-4  Con A  L3  20  45  50  10 
B18  20  47  40  43 
AKR-A  Con A  L3  30  35  36  1 
B18  30  26  23  31 
PHA  L3  30  39  26  27 
B18  30  0  0  0 
* L3 and B18 cells were preincubated with undiluted hybridoma supernatant  2.43 (anti-Lyt-2.2), 384.5, or 
with 20% AGH medium controls for 30 min at 4°C before the addition of 2.5 ×  103 SICr-labeled target 
ceils. Incubations were continued at 37°C for 90 min in the presence of 20 gg/ml Con A or 2 gg/ml PHA 
before the addition of EDTA. Incubations were continued for a total of 180 min. The results are expressed 
as the percent specific lysis  at the indicated effector/target  cell rzitios. 
antibody 384.5 was found to superimpose that of the second antibody (Fig. 2 B). These 
findings indicate that the antigenic determinant detected by antibody 384.5 is present 
on  L3  cells but  not  on  B18 cells. We have  found  no evidence of specific binding of 
antibody 384.5  to  11  other cytolytic or amplifier T  cell clones or to the P-815  target 
cells (data not shown). 
Normal  tissues, including preparations of spleen, lymph node,  thymus,  and  bone 
marrow cells from  C57BL/6  and  BDFa mice were tested for expression of the 384.5 
determinant. The results shown in Fig. 2 C  indicate that antibody 384.5  did not stain 
a  detectable portion of BDFa spleen cells. Similar results were obtained with each of 
the normal cell preparations of both C57BL/6  and BDF1 origin. 
Evidence for the  Clonal  Distribution  of Cells  Bearing  the  Determinant  Detected by Antibody 
384.5.  If  the  antigenic  determinant  recognized  by  antibody  384.5  represents  an 
idiotypic determinant on L3 cells, and if that idiotype were relatively common in the 
response of C57BL/6  mice to the H-2 a alloantigens, it might  be possible to identify 
cells bearing this  determinant  in  bulk  MLC  populations by using  flow cytofluoro- 
metric analysis. Antibody 384.5  did not stain a  detectable portion of primary MLC 
cells including 5-d unidirectional C57BL/6 spleen cells responding to DBA/2, B 10.D2, 
B10.A(5R), or CBA/J  stimulating cells (data not shown).  Fig. 3 shows the results of 
a  representative  experiment  in  which  antibody  384.5  was  reacted  with  C57BL/6 
spleen cells that had been stimulated twice in MLC. The fluorescence profile obtained 
with  C57BL/6  anti-CBA/J  MLC  cells when  examined with  antibody-384.5  super- 
imposed the  negative control  (9).  When  C57BL/6  anti-B10.A(5R)  MLC  cells were 
examined  (a combination that  genetically enriched  for MLC  cells reactive with  the 
H-2D a region gene products), a definite, though small population of cells reacted with 
the antibody 384.5.  Similar results were obtained with three separate preparations of 
C57BL/6  anti-B 10.A(5R)  MLC  cells. 
Evidence for the Endogenous  Synthesis of the Determinant Detected by Antibody 384.5.  As a 
preliminary step in determining the nature of the molecule bearing the determinant 
detected  by  antibody  384.5,  the  susceptibility  of  that  determinant  to  proteolytic 
digestion by trypsin was investigated. The loss of expression of the determinant by L3 380- 
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FIG.  2.  Flow cytofluoromc.tric analysis of the antigenic determinant recognized by antibody 384.5 
on two cytolytic T  lymphocyte clones and on normal BDFI lymph node cells. Cells were centrifuged 
over a discontinuous FicoH-Hypaque gradient, washed extensively, and distributed for fluorescence 
staining. A two-stage technique was used with staining at room temperature in the presence of 0.2% 
sodium  azide.  The  first  stage  antibody,  384.5,  or  control  monoclona]  reagent  as  indicated  was 
incubated under saturating conditions with  106 ceils  for 15 min. The second-stage antibody was a 
fluorescein-conjugated  rabbit  anti-mouse  Ig  in  all  experiments.  Cells  were  analyzed  by  flow 
cytofluorometry using a modified FACS IV as described in the text. In a]] experiments, 104 live ce}Is 
as determined by exclusion of propidium iodide were analyzed. Results are expressed in histogram 
form with the ordinate representing cell number, and the abscissa representing the log of fluorescence 
intensity in arbitrary units where one decade is represented by each gradation along the x axis. 
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FIG.  3.  Flow cytofluorometric analysis of the antigenic determinant recognized by antibody 384.5 
on secondary  MLC  cells.  C57BL/6  anti-CBA/J and  C57BL/6 anti-Bl0.A(5R)  MLC cells  were 
stimulated twice in vitro and then examined for expression of the antigenic determinant detected by 
antibody 384.5.  The  MLC  combination C57BL/6 anti-B10.A(5R)  genetically enriches for CTL 
specific for the H-2D d region. Preparation and staining methods are described in the legend for Fig. 
2. The second-step reagent was a fluorescein-conjugated rabbit anti-mouse Ig.  (9). 
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Fie.  4.  Effect  of trypsin  treatment  of L3  cells  on  the  relative expression  of the  determinant 
detected  by antibody 384.5.  Cloned  L3  cells  were  treated  with  the  indicated concentrations of 
trypsin as described in Materials and Methods. Cytofluorometric analysis (as described in Fig.  2) 
was used to determine the ability of antibody 384.5 to bind to freshly trypsinized L3 cells (0) or to 
L3 cells treated with trypsin (1000 ~g/ml) and then incubated overnight in medium (•).  The results 
are expressed as the percent maximum (untreated) L3 cell fluorescence with antibody 384.5. 
as a  result of trypsin treatment  was analyzed  using indirect imrnunofluorescence  and 
flow cytofluorometric  analysis.  The  results presented  in Fig.  4  show  that  the relative 
fluorescence  intensity  of the  L3  cells  stained  with  antibody  384.5  (expressed  as  a 
percentage of the fluorescence intensity of untrypsinized  L3 cells stained with antibody 930  T  CELL  CLONE-SPECIFIC  MONOCLONAL  ANTIBODY 
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F]c.  5.  Effect  of trypsin treatment  of L3 cells  on their cytolysis of P-815 target cells. L3 cells were 
treated with the indicated concentrations of trypsin as described in Materials and Methods. The 
relative cytolytic efficiency of the freshly trypsinized L3 ceils (0) or of L3 cells treated with trypsin 
(1,000 btg/ml) and then  incubated  overnight  in medium  (&) was determined  in a 3.5 h antigen- 
mediated cytolytic assay using 5 ×  10  a P-815 target cells. The results are expressed as the percent 
specific lysis  at various effector/target  cell ratios. 
384.5)  could  be  reduced  to  the  level  of staining  with  second  antibody  alone  by 
treatment for 30 min with trypsin concentrations _.I,000 ~g/m[. 
To determine if L3 cells were capable of reexpressing the determinant detected by 
antibody 384.5  after enzymatic treatment,  L3 cells treated with trypsin at a  concen- 
tration  of  1,000  ktg/ml  were  incubated  overnight  in  medium  without  filler cells at 
37°C.  The  results, shown  in  Fig. 4,  indicate that  after overnight  incubation  the L3 
cells stained with a  fluorescence intensity equivalent  to that  seen with untrypsinized 
control L3 cells. Similar results were observed in three separate experiments. 
The  effect of trypsin proteolysis on  L3  cell cytolytic activity was  also determined 
with  the same cell preparations used  for the analysis of enzyme susceptibility of the 
384.5  determinant. The effect of trypsin treatment  on  the capacity of the cloned L3 
cells to lyse P-815 target cells is shown in Fig. 5. The results indicate that the cytolytic 
efficiency of L3 cells decreased as a  function of the increasing trypsin concentration. 
L3  cells  treated  with  1,000  /*g/ml  of trypsin  and  incubated  overnight  in  medium 
recovered their cytolytic potential. 
Discussion 
Our approach in this study was designed to obtain monoclonal antibodies capable 
of inhibiting cytolytic activity of cloned CTL  in  a  clone-specific manner,  We have 
used the CTL clone L3 to immunize F1 animals by using a  procedure similar to that 
reported by Binz and Wigzell (6)  to produce "antiidiotypic" antisera. The choice of 
an  F1 hybrid mouse,  a  cross between  the strain of origin of the effector cell and  the 
strain  of origin  of the  target  cell,  should  favor  the  development  of clone-specific 
antibodies.  This  situation  minimizes  the  opportunity  for  production  of antibodies 
reactive with Lyt-2, 170/100, MHC, and other antigens shared by the CTL clone and 
the mouse being immunized.  It also lessens the chance  for production of antibodies 
having specificity for target cell antigens which might be adsorbed to the cloned CTL 
used in the immunization  (25). 
The antigen-mediated cytolytic process of CTL has been resolved into at least three LANCKI ET AL.  931 
steps (26): recognition-adhesion, the delivery of the lethal hit, and target cell distruc- 
tion. Recognition-adhesion may represent two separate steps, but they have not been 
functionally resolved. Recognition of antigen  is an essential element of the antigen- 
mediated cytolytic process, and antibodies directed against the recognition structures 
on  the  CTL  cell  surface  might  be expected  to  interfere  with  that  process.  In  the 
present study, we used a  microinhibition  screening procedure that was developed in 
this  laboratory  to  provide  a  sensitive  means  of detecting  monoclonal  antibodies 
reactive  with  cell  surface  structures  associated  with  the  cytolytic  process  (11).  By 
combining  the  F1  immunization  procedure  and  the  functional  screening  assay, we 
identified the monoclonal antibody 384.5 that inhibits the cytolysis by the CTL clone 
L3  but  does  not  inhibit  cytolysis by other  CTL  clones.  We  have  now  tested  the 
specificity of inhibition  of cytolysis by antibody 384.5 with >90 short-term cytolytic 
clones  derived  from  C57BL/6  anti-B10.A(5R)  MLC;  none  of  these  clones  were 
inhibited by the antibody 384.5. 
The specificity of inhibition of cytolysis by antibody 384.5 correlated well with the 
specificity of antibody binding as determined by flow cytofluorometry. The determi- 
nant  detected  by antibody 384.5  is expressed by the  L3 CTL clone,  but  not  by  12 
other cytolytic or amplifier T  lymphocyte long-term clones, nor was it expressed on a 
detectable portion of cells derived from normal tissues or alloreactive primary MLC 
of C57BL/6 origin. 
The  clone-specific  nature  of the  reactivity  of antibody  384.5  distinguishes  this 
antibody from other monoclonal antibodies  derived  in our laboratory such as anti- 
Lyt-2, anti-170/100,  or anti-H-2 antibodies that  inhibit  lytic activity of CTL clones 
nonspecifically (9).  Furthermore, our cytofluorometry data suggest that the determi- 
nant  detected  by antibody  384.5  is  expressed at  a  cell  surface density  much  lower 
than  that  of the  Lyt-2 molecular complex.  Although  the  determinant  detected  by 
antibody  384.5  is  distinct  from those  detected  by the other antibodies  that  inhibit 
cytolysis,  the  nature  of the  molecule  recognized  by  antibody  384.5  remains  to  be 
determined.  It  has  not  been  possible  thus  far  to  obtain  immunoprecipitates  with 
antibody  384.5.  This  difficulty  may  relate  to  the  low  level  of expression  of  the 
determinant with which this antibody reacts. 
Our results indicate that  the determinant  detected by antibody 384.5  is removed 
by proteolytic digestion.  Recent studies in this laboratory have shown that antigenic 
structures,  including  molecules  bearing  class  I  and  class  II  determinants,  can  be 
adsorbed  to the surface of cloned  cytolytic and  amplifier T  lymphocytes (25).  The 
determinant detected by antibody 384.5 does not appear to be acquired in this way. 
The  capacity of enzymatically treated  L3  cells  to  reexpress the  384.5  determinant 
after  overnight  incubation  indicates  that  the  cell  surface  molecule  bearing  this 
determinant is endogenously synthesized by the L3 cells. 
There are several potential mechanisms by which the antibody 384.5 may inhibit 
L3 cell cytolytic activity. The results of the binding studies suggest that the antibody 
inhibits cytolysis by binding specifically to the L3 effector cell and not to the target 
cell.  Furthermore,  these  studies  suggest  that  inhibition  is  probably  not  due  to 
nonspecific "blanketing" effects from high antigen density, because the cytofluorom- 
etry  studies  indicate  a  relatively  low  antigen  density  on  the  surface  of L3  cells. 
Antibody  384.5  is  not  directly  cytotoxic  to  L3  cells,  nor  does  it  appear to  induce 
effector cell  autolysis under  the conditions  of the  blocking assay as determined  by 932  T  CELL CLONE-SPECIFIC MONOCLONAL ANTIBODY 
51Cr-release assays or trypan blue exclusion assays (unpublished data). Antibody 384.5 
does not appear to inhibit cytolysis by binding directly to the molecule that delivers 
the lethal hit because this antibody specifically inhibits L3 cytolytic activity but not 
the  cytolytic  activity  of other  CTL  clones.  Furthermore,  antibody  384.5  did  not 
strongly inhibit  PHA-facilitated cytolysis of AKR-A target cells by L3 effector cells. 
The results of preliminary studies on the effects of antibody 384.5 on antigen-specific 
conjugate formation between L3 cells and P-815 target cells suggest that this antibody 
inhibits L3 cell lysis of P-815 target cells by interfering with the recognition-adhesion 
step of the cytolytic process. 
If the molecule bearing the determinant  recognized by antibody 384.5  is involved 
in antigen recognition, then enzymatic removal or alteration of that molecule might 
be expected to result in the loss of antigen-mediated cytolytic activity. The simulta- 
neous loss  by L3 cells of antigen-specific cytolytic activity and the expression of the 
antigenic determinant  detected by antibody 384.5  suggest that both properties have 
similar sensitivities to trypsin treatment. Results obtained in experiments that compare 
the susceptibility of L3 cell antigen-mediated cytolysis and lectin  (Con A)-facilitated 
cytolysis to  trypsin  treatment  (unpublished  data)  suggest  that  the  L3  CTL  clone 
antigen-mediated and lectin-facilitated cytolytic activities also have similar sensitivi- 
ties  to  trypsin  treatment.  Berke  et  al.  (27)  have  suggested  that  the  CTL  antigen 
receptor may play a role in cell-to-cell interactions that occur in lectin-facilitated lysis 
of irrelevant target cells.  If this is true, and if antibody 384.5 reacts with a determinant 
on the T  cell receptor, the ability of antibody 384.5 to inhibit both antigen-mediated 
and Con A-facilitated lysis is to be expected. 
The monoclonal antibody 384.5 represents a reasonable candidate for an antibody 
directed against a determinant on the CTL receptor. This antibody binds specifically 
to and inhibits cytolysis by the CTL clone L3 but  does not  bind to or inhibit several 
other CTL clones.  If antibody 384.5  recognizes an  idiotypic determinant  on the L3 
cell  antigen  receptor,  this  idiotype  does  not  appear  to  be  dominant  among  the 
C57BL/6  T  cell clonotypes that  respond  to  H-2 e  haplotype stimulation.  Cells from 
primary  5-d  MLC  which  react  with  antibody  384.5  have  not  been  detected  with 
certainty using flow cytofluorometric analysis  (data not shown).  However, when the 
cell  populations  are  derived  from  MLC  that  were  genetically  "enriched"  for cells 
reactive with determinants controlled by the H-2D d region [C57BL/6 anti-B 10.A(5R)] 
a  small  portion  of these  cells  have been  regularly observed  to stain  with  antibody 
384.5.  It is possible that these cells represent a clonally expanded subpopulation that 
share an idiotypic determinant with the L3 CTL clone. 
Antisera that appear to have antiidiotypic antibodies reactive with hapten-specific 
(7) or viral-specific (8) CTL have been produced by immunizing syngeneic mice with 
MLC cells that have cytolytic activity. Specificity for the appropriate CTL cells was 
suggested in these studies by the ability of these antisera to reduce cytolytic activity 
in the appropriate MLC cell preparations by treatment with antiserum and comple- 
ment (7, 8). However, none of these antisera inhibited cytolytic activity in the absence 
of complement (8).  Recently, antiidiotypic antisera have been produced by immuniz- 
ing F1 mice with cloned alloreactive noncytolytic T  cells (28). Although these antisera 
stimulated clone-specific proliferation, they appear also to contain antibodies which 
bind  to  irrelevant  clones  as  well  as  the  specific  clone  (C.  G.  Fathman,  personal 
communication). LANCKI ET AL.  933 
The clone-specific nature of the reactivity exhibited by the monoclonal antibody 
384.5  for a  cytolytic T  cell  appears to  be  unique.  This  clone-specific reactivity of 
antibody 384.5 was demonstrated both in its capacity to inhibit  L3 cytolysis and in 
its  ability  to  bind  to  L3.  The  specific pattern  suggests  that  this  antibody  may be 
reacting with the antigen-binding region of the antigen receptor on L3 CTL. 
Summary 
Monoclonal antibody 384.5 specifically inhibited cytolysis of P-815 target cells by 
cloned  L3 cytotoxic T  lymphocyte (CTL)  effector ceils.  The lytic activity of other 
cloned CTL that have other distinct specificities was not affected. Antibody 384.5 did 
not inhibit the cytolytic activity of bulk populations of C57BL/6 mixed lymphocyte 
culture  (MLC) cells. Concanavalin A-facilitated cytolysis by T  cell clone L3 but not 
T  cell  clone  BI8  was  inhibited  by  antibody  384.5,  whereas  phytohemagglutinin- 
facilitated  cytolysis by  L3  cells  was  not  strongly  inhibited.  Antibody  384.5  binds 
specifically to L3 cells but not to several other T  lymphocytes clones, or to a detectable 
portion of populations of primary MLC cells, normal spleen, thymus, lymph node, or 
bone  marrow  cells.  In  contrast,  C57BL/6  anti-B10.A(5R)  secondary  MLC  cells 
(genetically enriched for reactivity against the H-2D d region gene products) contained 
a small population which reacted with the antibody 384.5. The determinant detected 
by antibody  384.5  was susceptible  to  trypsin  treatment,  and  was  reexpressed  after 
overnight  incubation.  These  results  suggest  that  the  monoclonal  antibody  384.5 
detects  an endogenously  synthesized  clone-specific determinant  associated with  the 
cytolytic  activity of the  L3  CTL clone.  These  properties  make  antibody  384.5  an 
attractive candidate for an antibody that reacts with the antigen-recognition site of a 
cytolytic T  cell antigen receptor. 
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